查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1788282

全球病患控制鎮痛幫浦市場

Patient-Controlled Analgesic Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球病患控制止痛幫浦市場規模將達到 6.869 億美元

全球患者自控疼痛幫浦市場規模預計在2024年達到5.059億美元，預計2024年至2030年期間的複合年成長率為5.2%，到2030年將達到6.869億美元。本報告分析的細分市場之一－電子市場，預期複合年成長率為4.5%，到分析期間結束時市場規模將達到4.556億美元。機械市場在分析期間的複合年成長率預計為6.9%。

美國市場規模估計為 1.33 億美元，中國市場預計複合年成長率為 5.1%

美國患者自控止痛幫浦市場規模預計2024年達到1.33億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到1.104億美元，在2024-2030年的分析期間內，複合年成長率為5.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.5%和4.6%。在歐洲，德國市場的複合年成長率預計為4.3%。

全球病患控制鎮痛幫浦市場—主要趨勢與促進因素摘要

疼痛管理的新時代？患者自控式鎮痛幫浦的應用日益普及

疼痛管理已成為現代醫療保健的重點，而患者自控鎮痛 (PCA) 幫浦正在徹底改變疼痛緩解的給藥方式。 PCA 幫浦可讓患者透過靜脈、硬膜外或皮下注射自行管理止痛藥物，例如鴉片類藥物和局部麻醉劑。 PCA 幫浦廣泛應用於術後復健、癌痛管理和安寧療護，可提供個人化的疼痛緩解，同時減少對護理人員的依賴。與傳統的疼痛管理方法不同，PCA 幫浦能夠在預先設定的安全限度內按需給藥，從而最大限度地降低過量用藥和副作用的風險。慢性疼痛盛行率的不斷上升、手術量的不斷增加以及先進的疼痛管理通訊協定，正在推動醫院、門診手術中心和家庭護理機構對 PCA 泵的需求。隨著全球鴉片類藥物危機引發人們對處方藥濫用的擔憂，PCA 技術正在不斷改進，以納入劑量限制功能、智慧藥物監測和電子健康記錄(EHR) 整合，以確保安全有效的疼痛管理。隨著醫療保健提供者優先考慮以患者為中心的方法，PCA 幫浦正在成為增強疼痛管理和提高患者滿意度的首選解決方案。

智慧技術如何為PCA幫浦提供動力：人工智慧、無線監控和藥物安全創新

智慧技術的整合正在改變 PCA 泵，使其更安全、更有效率，並更好地融入現代醫療保健系統。先進的 PCA 幫浦現配備無線連接功能，可讓醫療保健提供者進行即時遠端監控，防止發生過量用藥事件，並確保最佳的疼痛管理。 PCA 設備中正在內建人工智慧演算法，以分析患者反應，檢測鴉片類藥物引起的呼吸抑制的早期跡象，並相應地調整給藥參數。閉合迴路給藥系統和條碼藥物驗證等藥物輸送創新進一步提高了 PCA 幫浦的準確性，減少了用藥錯誤，並確保遵守醫院安全通訊協定。具有輸液分析功能的智慧 PCA 幫浦可以追蹤患者的使用模式，並提供預測性見解以最佳化疼痛管理。與醫院 EHR 的整合可以實現藥物管理的自動記錄，提高臨床工作流程效率和法規遵循。非侵入性 PCA 技術的發展，包括經皮和鼻腔給藥系統，也因向患者提供無針止痛選擇而越來越受歡迎。隨著數位健康生態系統的發展，人工智慧、數據分析和連網型設備的融合正在重塑 PCA 泵格局，使疼痛管理更安全、更有效。

PCA泵浦在哪些領域使用？醫療保健領域應用日益廣泛

PCA幫浦正成為醫院、門診外科中心、安寧療護和居家醫療保健機構疼痛管理的重要組成部分。在醫院，PCA幫浦廣泛應用於術後恢復室，用於管理大型手術（包括整形外科、心血管和腹部手術）後的急性疼痛。癌症治療中心利用PCA技術幫助患者控制嚴重的癌症相關疼痛，並確保在化療和安寧療護期間持續緩解疼痛。家庭醫療保健機構擴大部署可攜式PCA泵，使慢性疼痛患者能夠在家中控制疼痛。門診手術中心正在將PCA設備整合到當日手術護理方案中，以實現有效的疼痛緩解並縮短恢復時間。 PCA幫浦也被用於兒科和老年病科，其特殊的安全功能旨在最大限度地降低弱勢患者群體的風險。軍隊和創傷部門正在探索將PCA技術用於戰場傷病管理，為偏遠地區的受傷士兵提供快速的疼痛緩解。隨著醫療機構不斷採用先進的疼痛管理解決方案，各種醫療機構對PCA幫浦的需求都在成長。

患者控制疼痛泵市場的成長受到多種因素的推動…

全球外科手術發生率的上升是推動PCA泵市場成長的主要因素。癌症、關節炎和神經病變疼痛等慢性疼痛疾病的日益流行，推動了對先進疼痛管理解決方案的需求。以病人為中心的照護模式的轉變，推動了醫療保健提供者對PCA幫浦的採用，使病人在疼痛管理方面擁有更大的自主權。人工智慧監控、無線連接和自動化給藥控制等技術進步，使PCA幫浦更安全、更有效率。人們對鴉片類藥物濫用和過量攝取的擔憂日益加劇，這促使人們開發出具有增強用藥安全功能的智慧PCA幫浦。家庭醫療保健和遠端患者監護的擴展，為攜帶式和穿戴式PCA設備創造了新的機會。促進安全疼痛管理實踐和鴉片類藥物管理計劃的監管要求，正在推動醫院和醫療機構採用PCA泵。對數位醫療基礎設施的持續投資，促進了PCA泵與醫院電子健康記錄(EHR) 和臨床決策支援系統的無縫整合。醫療設備和製藥公司之間的策略聯盟正在推動疼痛緩解技術的創新。隨著醫療保健系統不斷向精準醫療和數據主導的疼痛管理策略發展，患者控制疼痛幫浦市場有望持續成長，並將改變疼痛治療的未來。

部分

類型（電子、機械）、應用（糖尿病、腫瘤學、胃腸病學、血液學、其他）、最終用途（醫院、專科診所、門診手術中心、居家醫療機構）

受訪公司範例

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company（BD）
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc.（Hospira）
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical（ICU Medical）
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP32496

Global Patient-Controlled Analgesic Pumps Market to Reach US$686.9 Million by 2030

The global market for Patient-Controlled Analgesic Pumps estimated at US$505.9 Million in the year 2024, is expected to reach US$686.9 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Electronic, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$455.6 Million by the end of the analysis period. Growth in the Mechanical segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$133.0 Million While China is Forecast to Grow at 5.1% CAGR

The Patient-Controlled Analgesic Pumps market in the U.S. is estimated at US$133.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Patient-Controlled Analgesic Pumps Market - Key Trends & Drivers Summarized

Is Pain Management Entering a New Era? The Growing Adoption of Patient-Controlled Analgesic Pumps

Pain management has become a critical focus in modern healthcare, with patient-controlled analgesic (PCA) pumps revolutionizing the way pain relief is administered. These devices empower patients to manage their own pain by delivering controlled doses of analgesic medication, typically opioids or local anesthetics, through intravenous (IV), epidural, or subcutaneous routes. PCA pumps are widely used in post-surgical recovery, cancer pain management, and palliative care, offering personalized pain relief while reducing dependency on nursing staff. Unlike conventional pain management methods, PCA pumps allow for on-demand drug administration within predefined safety limits, minimizing the risk of overmedication and adverse effects. The increasing prevalence of chronic pain conditions, rising surgical volumes, and advancements in pain management protocols are driving the demand for PCA pumps across hospitals, ambulatory surgical centers, and home care settings. With the global opioid crisis raising concerns over prescription drug misuse, PCA technology is being refined to incorporate dose-limiting features, smart drug monitoring, and electronic health record (EHR) integration to ensure safe and effective pain management. As healthcare providers prioritize patient-centered approaches, PCA pumps are emerging as a preferred solution for enhancing pain control and improving patient satisfaction.

How Are Smart Technologies Enhancing PCA Pumps? AI, Wireless Monitoring & Drug Safety Innovations

The integration of smart technologies is transforming PCA pumps, making them safer, more efficient, and better integrated into modern healthcare systems. Advanced PCA pumps now feature wireless connectivity, allowing real-time remote monitoring by healthcare providers to prevent overdose incidents and ensure optimal pain management. AI-powered algorithms are being incorporated into PCA devices to analyze patient responses, detect early signs of opioid-induced respiratory depression, and adjust dosage parameters accordingly. Drug safety innovations such as closed-loop drug delivery systems and barcode medication verification are further enhancing the accuracy of PCA pumps, reducing medication errors, and ensuring compliance with hospital safety protocols. Smart PCA pumps equipped with infusion analytics can track patient usage patterns and provide predictive insights for pain management optimization. Integration with hospital EHRs enables automated documentation of drug administration, improving clinical workflow efficiency and regulatory compliance. The development of non-invasive PCA technologies, including transdermal and intranasal drug delivery systems, is also gaining traction, offering patients needle-free pain relief options. As digital health ecosystems evolve, the convergence of AI, data analytics, and connected devices is reshaping the PCA pump landscape, making pain management safer and more effective.

Where Are PCA Pumps Being Used? Expanding Adoption Across Healthcare Settings

PCA pumps are becoming an essential component of pain management in hospitals, outpatient surgical centers, palliative care, and home healthcare settings. In hospitals, PCA pumps are widely used in post-operative recovery units to manage acute pain following major surgeries such as orthopedic, cardiovascular, and abdominal procedures. Cancer treatment centers are leveraging PCA technology to help patients manage severe cancer-related pain, ensuring continuous relief during chemotherapy and palliative care. Home healthcare providers are increasingly deploying portable PCA pumps to allow patients with chronic pain conditions to receive controlled analgesia in a home setting, reducing hospital visits and improving quality of life. Ambulatory surgical centers are integrating PCA devices into same-day surgical care protocols, enabling efficient pain relief with faster recovery times. Pediatric and geriatric care settings are also adopting PCA pumps, with specialized safety features designed to minimize risks in vulnerable patient populations. Military and trauma care units are exploring the use of PCA technology for battlefield injury management, providing rapid pain relief to injured soldiers in remote locations. As healthcare facilities continue to embrace advanced pain management solutions, the demand for PCA pumps is growing across diverse medical environments.

The Growth in the Patient-Controlled Analgesic Pumps Market Is Driven by Several Factors…

The rising incidence of surgical procedures worldwide is a key driver fueling the growth of the PCA pump market. The increasing prevalence of chronic pain conditions such as cancer, arthritis, and neuropathic pain is boosting demand for advanced pain management solutions. The shift toward patient-centric care models is driving healthcare providers to adopt PCA pumps, enhancing patient autonomy in pain management. Technological advancements, including AI-powered monitoring, wireless connectivity, and automated drug dose control, are making PCA pumps safer and more efficient. The rising concerns over opioid misuse and overdose are leading to the development of smart PCA pumps with enhanced drug safety features. The expansion of home healthcare and remote patient monitoring is creating new opportunities for portable and wearable PCA devices. Regulatory mandates promoting safe pain management practices and opioid stewardship programs are encouraging the adoption of PCA pumps in hospitals and healthcare institutions. The increasing investment in digital health infrastructure is facilitating seamless integration of PCA pumps with hospital electronic health records (EHRs) and clinical decision support systems. Strategic collaborations between medical device manufacturers and pharmaceutical companies are driving innovations in pain relief technologies. As healthcare systems continue to evolve toward precision medicine and data-driven pain management strategies, the patient-controlled analgesic pump market is set for sustained growth, transforming the future of pain therapy.

SCOPE OF STUDY:

The report analyzes the Patient-Controlled Analgesic Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Electronic, Mechanical); Application (Diabetes, Oncology, Gastroenterology, Hematology, Others); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Home Care Settings)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc. (Hospira)
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical (ICU Medical)
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Patient-Controlled Analgesic Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Post-Surgical Pain Management Protocols Accelerates Demand for Patient-Controlled Analgesic Pumps
    • Focus on Personalized Pain Therapy Drives Adoption of PCA Devices
    • Growth in Ambulatory Surgical Centers Expands Use of Portable Analgesic Pumps
    • Integration with Digital Health Records Strengthens Monitoring and Control Capabilities
    • Rising Opioid Safety Concerns Throw the Spotlight on Controlled Drug Delivery Solutions
    • Demand for Non-Invasive Pain Management Spurs Innovation in Pump-Based Therapies
    • Increasing Patient Preference for Self-Managed Pain Relief Drives PCA Device Utilization
    • AI-Enhanced Dosage Monitoring Improves Accuracy and Minimizes Overdose Risk
    • Regulatory Scrutiny on Drug Delivery Devices Spurs Development of Tamper-Resistant Pumps
    • Hospital Efforts to Reduce Nursing Workload Strengthen Use of Automated PCA Systems
    • Expansion of Home Recovery Programs Supports Demand for Compact, User-Friendly Pumps
    • Growth in Pediatric and Geriatric Surgery Volumes Creates Niche PCA Product Demand
    • Clinical Trials Supporting Efficacy Drive Confidence and Market Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient-Controlled Analgesic Pumps Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electronic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electronic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Mechanical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • JAPAN
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CHINA
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • EUROPE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • FRANCE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • GERMANY
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030

IV. COMPETITION